Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial
Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page
- Check7 days agoChange DetectedThe page footer revision was updated from v3.6.4 to v3.6.5, indicating a new release of the page. This update reflects version control rather than substantive changes to the study details.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe sponsor entity name was updated to Gossamer Bio USA, Inc. (GB005, Inc.), and the page revision progressed from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now displays Revision: v3.6.3 in place of Revision: v3.6.2, indicating an update to the interface version. This is a UI/versioning change and does not alter the study data or its presentation beyond the version label.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now shows a new revision tag indicating v3.6.2, updating the page's version label. This reflects an internal update to the page template rather than changes to study data or content.SummaryDifference0.1%

- Check63 days agoChange DetectedRecruitment status is now shown as 'No longer looking for participants', indicating the study is not enrolling. The page also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' with a revision tag updated to v3.6.0.SummaryDifference0.5%

- Check71 days agoChange DetectedThe page shows a revision label updated from v3.5.4 to v3.5.5, indicating a newer page template version. This is a technical update and does not modify study details, eligibility criteria, results, or other substantive content.SummaryDifference0.1%

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.